Geron (GERN) grants director 270,000 stock options at $1.57

Rhea-AI Filing Summary

Geron Corporation director Patricia S. Andrews received a grant of 270,000 stock options to buy Geron common stock. The options have an exercise price of $1.57 per share and expire on March 24, 2036. They vest in three equal annual installments starting on March 25, 2027, contingent on her continued service. Following this grant, she holds 270,000 stock options directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Andrews Patricia S

(Last) (First) (Middle)

C/O GERON CORPORATION

919 EAST HILLSDALE BOULEVARD, SUITE 250

(Street)

FOSTER CITY CALIFORNIA 94404

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GERON CORP [ GERN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$1.57	03/25/2026		A		270,000		(1)	03/24/2036	Common Stock	270,000	$0	270,000	D

Explanation of Responses:

1. The option shall vest and become exercisable in three equal annual installments starting on March 25, 2027, subject to the Reporting Person's continuous service (as defined in the Issuer's 2018 Equity Incentive Plan) with the Issuer through each such vesting date.

	/s/ Michelle Robertson, Attorney-in-Fact	03/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Geron (GERN) director Patricia S. Andrews receive in this Form 4?

Patricia S. Andrews received a grant of 270,000 stock options. These options give her the right to buy Geron common stock at $1.57 per share, subject to vesting conditions and an expiration date in March 2036.

What is the exercise price and term of the new Geron (GERN) stock options?

The granted options have an exercise price of $1.57 per share and expire on March 24, 2036. This defines the fixed price Andrews can pay for shares and the final date she can exercise the options.

How do the Geron (GERN) stock options granted to Patricia Andrews vest?

The options vest in three equal annual installments starting March 25, 2027. Each installment requires Patricia Andrews to maintain continuous service with Geron through the applicable vesting date under the company’s 2018 Equity Incentive Plan.

How many Geron (GERN) stock options does Patricia Andrews hold after this grant?

After this grant, Patricia Andrews holds 270,000 stock options directly. The Form 4 shows this total as the number of derivative securities beneficially owned following the reported acquisition of the new option award.

Is the Geron (GERN) Form 4 transaction a purchase or a compensation grant?

The transaction is a compensation-related grant, not an open-market purchase. It is coded as an acquisition (code A) representing a stock option award under Geron’s equity incentive plan, with no cash purchase of shares reported.